Published on
October 26, 2023
- 15:57 GMT
MeCo Diagnostics and Unravel Biosciences announce a prostate cancer biomarker and drug discovery partnership
Partnership unlocks synergies to rapidly identify and evaluate novel biomarker-targeted therapies for solid tumors, starting with prostate cancer SAN DIEGO, CALIFORNIA, US, October 26, 2023 /EINPresswire.com/ -- MeCo Diagnostics Holdings, Inc. (“MeCo”) …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
